ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin.

Abstract excerpt

The ABCG2 c.421C>A single-nucleotide polymorphism (SNP) was determined in 660 healthy Finnish volunteers, of whom 32 participated in a pharmacokinetic crossover study involving the administration of 20 mg atorvastatin and rosuvastatin. The frequency of the c.421A variant allele was 9.5% (95% confidence interval 8.1-11.3%). Subjects with the c.421AA genotype (n = 4) had a 72% larger mean area under the plasma...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anticholesteremic Agents
• Share to Atorvastatin
• Share to ATP Binding Cassette Transporter, Subfamily G, Member 2